Geode Capital Management’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Sell |
73,100
-19
| -0% | -$28 | ﹤0.01% | 4036 |
|
|
2025
Q1 | $104K | Buy |
73,119
+4,229
| +6% | +$6.01K | ﹤0.01% | 4022 |
|
|
2024
Q4 | $139K | Buy |
68,890
+2,630
| +4% | +$5.31K | ﹤0.01% | 4004 |
|
|
2024
Q3 | $117K | Buy |
66,260
+1,428
| +2% | +$2.51K | ﹤0.01% | 4060 |
|
|
2024
Q2 | $151K | Buy |
64,832
+4,400
| +7% | +$10.3K | ﹤0.01% | 4007 |
|
|
2024
Q1 | $86.4K | Hold |
60,432
| – | – | ﹤0.01% | 4205 |
|
|
2023
Q4 | $103K | Hold |
60,432
| – | – | ﹤0.01% | 4182 |
|
|
2023
Q3 | $113K | Sell |
60,432
-9,102
| -13% | -$17K | ﹤0.01% | 4206 |
|
|
2023
Q2 | $166K | Hold |
69,534
| – | – | ﹤0.01% | 4123 |
|
|
2023
Q1 | $138K | Hold |
69,534
| – | – | ﹤0.01% | 4214 |
|
|
2022
Q4 | $134K | Buy |
69,534
+2,084
| +3% | +$4.02K | ﹤0.01% | 4284 |
|
|
2022
Q3 | $235K | Hold |
67,450
| – | – | ﹤0.01% | 4112 |
|
|
2022
Q2 | $331K | Buy |
67,450
+733
| +1% | +$3.6K | ﹤0.01% | 3977 |
|
|
2022
Q1 | $440K | Hold |
66,717
| – | – | ﹤0.01% | 3997 |
|
|
2021
Q4 | $520K | Hold |
66,717
| – | – | ﹤0.01% | 4022 |
|
|
2021
Q3 | $840K | Buy |
66,717
+20,189
| +43% | +$254K | ﹤0.01% | 3775 |
|
|
2021
Q2 | $697K | Buy |
46,528
+17,704
| +61% | +$265K | ﹤0.01% | 3781 |
|
|
2021
Q1 | $480K | Buy |
28,824
+1,181
| +4% | +$19.7K | ﹤0.01% | 3832 |
|
|
2020
Q4 | $451K | Buy |
27,643
+6,360
| +30% | +$104K | ﹤0.01% | 3622 |
|
|
2020
Q3 | $237K | Sell |
21,283
-696
| -3% | -$7.75K | ﹤0.01% | 3669 |
|
|
2020
Q2 | $400K | Buy |
21,979
+18,489
| +530% | +$336K | ﹤0.01% | 3444 |
|
|
2020
Q1 | $29K | Buy |
+3,490
| New | +$29K | ﹤0.01% | 4004 |
|